Protamine Crystallised Insulin Aspart is a combination of two types of insulin: insulin aspart, a rapid-acting insulin analogue, and protamine, which extends the action of insulin by forming a suspension. This combination is used to manage blood glucose levels in patients with diabetes mellitus, providing both rapid and prolonged glycemic control.
Protamine Crystallised Insulin Aspart is primarily used for:
| Brand Name | Protamine Crystallised Insulin Aspart |
|---|---|
| Type | |
| Weight | |
| Generic | Protamine Crystallised Insulin Aspart |
| Manufacturer | |
| Available in | English বাংলা |
Insulin aspart, the rapid-acting component, lowers blood glucose levels by promoting the uptake of glucose into cells and inhibiting glucose production in the liver. Protamine prolongs the action of insulin aspart by forming a complex that delays the absorption of insulin, providing extended duration of glucose control.
Insulin aspart begins to work within about 15 minutes after injection, reaching peak action in 1 to 3 hours. The protamine component extends the duration of action, which can last up to 24 hours, depending on the individual’s metabolism and other factors.
After subcutaneous injection, insulin aspart is rapidly absorbed into the bloodstream. The addition of protamine delays the absorption, providing a more gradual release and extending the duration of insulin activity. The onset of action for the combined formulation is slower compared to insulin aspart alone due to the protamine component.
Insulin aspart and protamine are metabolized primarily in the liver and kidneys. Insulin is degraded by insulinase and other proteolytic enzymes, with metabolites excreted in the urine. Protamine is broken down by tissue proteases and also excreted through the kidneys.
The dosage of Protamine Crystallised Insulin Aspart should be individualized based on the patient's needs, blood glucose levels, and overall treatment goals. Typical dosing regimens may involve:
Protamine Crystallised Insulin Aspart is administered subcutaneously. Common injection sites include the abdomen, thighs, or upper arms. It is important to rotate injection sites to prevent lipodystrophy and ensure consistent absorption. It is not intended for intravenous use.
Common side effects include:
Serious side effects can include:
Toxicity primarily results from overdose, leading to severe hypoglycemia. Symptoms of hypoglycemia include confusion, dizziness, tremors, and loss of consciousness. Immediate treatment involves administering glucose orally or intravenously, depending on the severity of the hypoglycemic episode.
Precautions include:
Drug interactions can occur with various medications, including:
Use with caution in patients with:
Potential drug interactions include:
Food intake can affect blood glucose levels and insulin requirements. It is important to maintain a consistent diet and monitor blood glucose levels regularly. Meals should be timed to correspond with insulin administration to avoid hypoglycemia or hyperglycemia.
Protamine Crystallised Insulin Aspart is generally considered safe during pregnancy. However, insulin needs may change, and careful monitoring of blood glucose levels is required. Pregnant women should consult their healthcare provider for personalized recommendations and adjustments in dosage.
Insulin aspart is excreted in breast milk in very small amounts, and its use during lactation is considered safe. However, monitoring of blood glucose levels is important for both the mother and the infant. Consult a healthcare provider for any specific concerns related to breastfeeding and insulin therapy.
An acute overdose of Protamine Crystallised Insulin Aspart can lead to severe hypoglycemia. Symptoms include confusion, sweating, rapid heartbeat, and loss of consciousness. Treatment involves administering glucose or glucagon and monitoring the patient closely until blood glucose levels stabilize.
Protamine Crystallised Insulin Aspart is contraindicated in patients with:
Follow the prescribed dosage and administration instructions carefully. Administer the medication subcutaneously and rotate injection sites to minimize local reactions. Regularly monitor blood glucose levels and adjust the dosage based on individual needs and response to treatment.
Store Protamine Crystallised Insulin Aspart in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. After opening, it can be stored at room temperature for up to 28 days. Protect from light and keep out of reach of children.
The volume of distribution for insulin aspart is approximately 0.1 to 0.2 L/kg, indicating its distribution into body tissues and fluids. The protamine component affects the distribution and prolongs the duration of action.
The half-life of insulin aspart is approximately 1 to 2 hours, while the protamine component extends the duration of action, which can last up to 24 hours. The effective half-life of the combined formulation is influenced by the protamine's prolonged release effect.
Insulin aspart is cleared primarily through hepatic metabolism and renal excretion. The presence of protamine affects the clearance rate by slowing down the absorption and metabolism of insulin, thereby prolonging its action and maintaining blood glucose control.
See in details version Protamine Crystallised Insulin Aspart also Protamine Crystallised Insulin Aspart in bangla
Protamine Crystallised Insulin Aspart is a combination insulin formulation that includes both rapid-acting insulin aspart and a protamine-crystallized form that extends its duration of action. It helps manage blood sugar levels in individuals with diabetes.
It works by mimicking the body's natural insulin response. The insulin aspart component acts quickly to lower blood sugar levels after meals, while the protamine-crystallized component provides a longer duration of action to maintain stable blood sugar levels.
It is used for the treatment of both type 1 and type 2 diabetes to help regulate blood glucose levels and prevent complications associated with diabetes.
It is administered via subcutaneous injection, typically in the abdomen, thigh, or upper arm. The injection site should be rotated to avoid skin complications.
It is usually taken once or twice daily before meals, as prescribed by a healthcare provider.
It starts working within 10-20 minutes after injection, with peak effects occurring within 1-4 hours.
The duration of action typically lasts up to 24 hours, with a prolonged effect due to the protamine component.
It can be used alone or in combination with other antidiabetic medications such as metformin, depending on the patient’s needs.
Common side effects include:
- Hypoglycemia (low blood sugar)
- Injection site reactions (redness, swelling, itching)
- Weight gain
- Mild swelling in the legs or hands
Serious side effects include:
- Severe hypoglycemia (leading to unconsciousness or seizures)
- Allergic reactions (rash, difficulty breathing, swelling of face or throat)
- Lipodystrophy (changes in fat distribution at injection sites)
Yes, some individuals may experience weight gain due to improved glucose metabolism and increased appetite.
Yes, hypoglycemia is a common side effect, especially if the dosage is too high or meals are skipped.
If you miss a dose, take it as soon as you remember unless it is close to your next scheduled dose. Do not double the dose to compensate.
It is considered safe for use in pregnancy, but insulin needs may change during pregnancy, so dose adjustments may be required.
Yes, it is generally safe, but you should consult a doctor for appropriate dosage adjustments.
- Unopened vials should be stored in the refrigerator (2-8°C).
- Opened vials can be stored at room temperature for up to 28 days.
- Avoid freezing.
Alcohol can affect blood sugar levels and increase the risk of hypoglycemia, so it should be consumed cautiously.
Yes, it is approved for use in children with diabetes, but the dosage must be carefully managed.
Yes, but they may require dosage adjustments due to slower metabolism and increased risk of hypoglycemia.
No, it should not be mixed with other insulin types in the same syringe.
Yes, it can be used in combination with oral diabetes drugs like metformin and sulfonylureas.
An overdose can cause severe hypoglycemia, leading to confusion, unconsciousness, seizures, or even death. Emergency medical attention is required.
Rarely, it may cause allergic reactions such as rash, swelling, and difficulty breathing.
Patients with kidney disease may require lower doses as insulin clearance is reduced.
Yes, but liver disease can affect insulin metabolism, requiring dose adjustments.
Yes, it is commonly prescribed for type 1 diabetes.
Yes, it is effective for type 2 diabetes, particularly when oral medications are insufficient.
Yes, but monitor blood sugar levels, as exercise can lower blood glucose.
Improper dosing, missed doses, or insulin resistance can cause high blood sugar (hyperglycemia).
Alternate between different areas (abdomen, thighs, arms) to prevent skin complications.
Yes, carry insulin in a cool pack and bring extra supplies.
Yes, but be cautious of hypoglycemia, which can impair concentration.
Yes, but dosage adjustments are needed under medical supervision.
A balanced diet with consistent carbohydrate intake helps maintain stable blood sugar.
Consume fast-acting carbohydrates like glucose tablets or fruit juice and seek medical help if severe.
Yes, it is sometimes prescribed for gestational diabetes under medical guidance.
No, stopping insulin without a doctor's advice can lead to severe hyperglycemia and ketoacidosis.
Dr. Lubna Khondker
Skin, Hair, Nail, STDs, Cosmetology, Dermatosurgery & Laser Treatment Specialist
Prof. Dr. Manzoor Mahmood
Cardiology (Heart Diseases, Hypertension, Rheumatic Fever) Specialist